Source: International Congress 2014 – PG12 The omics revolution: the future of personalised medicine



Rating:

Share or cite this content

Citations should be made in the following way:
R. Chen (Stanford, United States of America). Integrated omics predicts clinical outcomes. International Congress 2014 – PG12 The omics revolution: the future of personalised medicine

Member's Comments

Branislava Milenković - 13.04.2015 09:44
Great!

Related content which might interest you: Personal ‘omics profiling Source: ERS Lung Science Conference 2016 Year: 2016 Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Linking clinical algorithms to precision medicine Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action Year: 2020 How can real-world data be used to improve outcomes? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 A data management and analysis platform for RASP-UK multiomics clinical datasets Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Integration of multi-omics datasets enables molecular classification of COPD Source: Eur Respir J, 51 (5) 1701930; 10.1183/13993003.01930-2017 Year: 2018 Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Atmospheric simulation chamber: a versatile tool to get a comprehensive understanding of Air Quality impacts on health in preclinical models Source: International Congress 2018 – Occupational and environmental lung diseases: air quality and lung damage Year: 2018 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 The omics approach to defining endotypes and personalising treatment pathways in asthma Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 eTRIKS IT platfroms for large-scale biomedical research Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 A multi-omics data integration approach to identify a predictive molecular signature of CLAD Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 Biomarker technologies: 4-dimensional research  Source: International Congress 2017 – Innovation in diagnosing and monitoring respiratory disease Year: 2017 Clinical efficacy of the COPDnet integrated care model Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care Year: 2020 Clinical prediction guides in COPD, a real life evaluation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013